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ABSTRACT
BACKGROUND: Tritrichomonas foetus (T. foetus) is a flagellated protozoa that infects the
distal ileum and proximal colon of domestic cats and also induces reproductive failure in cattle.
Although feline trichomonosis is recognized to have a global prevalence of up to 30%, it still
poses a diagnostic and therapeutic challenge to veterinarians; thus, there is a need for both
improved diagnostics and therapeutics. Despite differing organ tropism between genotypes,
evidence exists for conserved virulence factors between feline and bovine T. foetus. Two
epitopes (1.15 and 1.17) of the bovine T. foetus glycosylated surface antigen 1.15-1.17 have been
found to facilitate adhesion and cytotoxicity towards bovine urogenital epithelium. Although
epitope 1.15 has been previously identified in feline isolates, conservation and function of
epitope 1.17 has not yet been evaluated.
METHODS: Western blotting and indirect immunofluorescence were used to identify the
presence of 1.15-1.17 in feline T. foetus isolates. One bovine T. foetus and one feline
Pentatrichomonas hominis (a non-pathogenic feline trichomonad) isolate were used as positive
and negative controls for all assays. Validated co-culture assays with in vitro porcine jejunal
epithelial cell (IPEC-J2) cultures were used to determine the role this antigen plays in mediating
adherence and cytotoxicity to the intestinal epithelium. Confluent epithelial cells were infected
with feline T. foetus either treated with 1) isotype control or 2) 1:100 monoclonal antibody, and
co-cultured for either 6 (i.e. adhesion assays) or 24 hours (i.e. cytotoxicity studies).
RESULTS: Presence and surface localization of both epitopes in feline T. foetus isolates was
confirmed via western blotting, immunofluorescence and flow cytometry. Co-culture adhesion
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and cytotoxicity assays showed that epitopes 1.15 and 1.17 were either found to decrease or have
no role in adhesion of T. foetus to intestinal epithelial cells.
CONCLUSIONS: Discovery of this antigen in feline T. foetus provides continued evidence that
similarities exist between the bovine and feline genotypes. Although the role of 1.15-1.17 differs
in feline versus bovine T. foetus in vitro, the conservation of expression across isolates and
surface location of these epitopes are ideal characteristics for engineering a novel diagnostic
assay for detection of whole organism trichomonads in fecal samples.
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CHAPTER ONE: LITERATURE REVIEW
Introduction to Trichomonads
Members of the family Trichomonadidae and subfamily Tritrichomonadidae are
eukaryotic protozoa that inhabit the urogenital, gastrointestinal and respiratory tracts of their
respective hosts. All trichomonads belong to the class Parabasalia, and range in size from
approximately 10-20 µm. The earliest classification systems for trichomonads identified
organisms based on their morphological characteristics (i.e. a parabasal body, dorsal undulating
membrane and axostyle) and differentiated between species based on their number of anterior
flagella, which vary from 3 to 5 in number. (Cavalier-Smith, 1993; Schwebke and Burgess,
2004) Trichomonads are classified as microaerophilic organisms; they colonize organ systems
with exposure to the outside environment, but require only low oxygen concentration. (<10%).
(Mack and Muller, 1978) These organisms reproduce via binary fission, and unlike other
protozoa (e.g. Giardia spp.), lack a cyst stage. Another hallmark of trichomonads is that, unlike
many other eukaryotes, they lack mitochondria and instead possess a common organelle, called
the hydrogenosome, which functions to degrade carbohydrate substrates to produce acid (i.e.
hydrogen) as an end product. This structure is imperative for anaerobic pyruvate metabolism and
subsequent energy production for the protozoa, making it necessary for trichomonad survival.
(Benchimol et al., 1996; Lindmark and Muller, 1973). Therefore, these structures have been
important targets for anti-protozoal therapies.
Trichomonads include Trichomonas spp., Tritrichomonas spp., Tetratrichomonas spp.
and Pentatrichomonas spp., and consist of both pathogenic and non-pathogenic protozoa. Wellrecognized and studied pathogenic species include the human and bovine venereal trichomonads,
1

Trichomonas vaginalis and Tritrichomonas foetus, respectively, as well as the avian
trichomonad, Trichomonas gallinae. Trichomonas vaginalis is now recognized to be the most
common non-viral sexually transmitted disease in humans worldwide. It is responsible for over
200 million cases of trichomoniasis annually, and the infection increases the risk of human
immunodeficiency virus (HIV) contraction in comparison to non-infected individuals. (Kissinger
and Adamski, 2013) The discovery and study of virulence factors integral to T. vaginalis
cytopathogenicity (including adhesin proteins and proteases) have provided a foundation for
studies on the pathogenicity of other trichomonad species, namely Tritrichomonas foetus.
Multiple Virulence Factors are Conserved Across Trichomonad Species
Both the human venereal pathogen, Trichomonas vaginalis, and bovine T. foetus have provided
an important foundation in identification of virulence factors that have broad implications for
most pathogenic trichomonad species. Several virulence factors have been identified as
important mediators of cytopathogenicity in trichomonads infecting both humans and animals.
These include glycoproteins (Hodgson et al., 1990; Petropolis et al., 2008; Shaia et al., 1998;
Silva-Filho et al., 2002) and lipophosphoglycans (Fichorova et al., 2006; Singh, 1994; Singh et
al., 2001; Singh et al., 1999), which have been shown as integral in facilitating adhesion to the
host epithelium. Enzymes such as cysteine proteases have also been identified to play an
important role in both mediating adhesion to, as well as exerting cytotoxicity towards epithelial
cells. (Arroyo and Alderete, 1989; Lucas et al., 2008; Singh et al., 2005; Tolbert et al., 2014)
Identification of Bovine Tritrichomonas foetus as a Venereal Pathogen
Tritrichomonas foetus (T. foetus) is a flagellated protozoal pathogen responsible for
reproductive failure (i.e. endometritis, infertility, early embryonic death and abortions) in cattle.
2

Bovine T. foetus is reported to have first appeared as a venereal pathogen following culture of
the protozoa from herds of dairy cattle in eastern Australia, with subsequent identification of the
pathogen in beef herds throughout the country. (Dennett et al., 1974; Parsonson et al., 1974) The
first cultures were harvested from the preputial cavity of bulls, which serve as asymptomatic
carriers of the pathogen. The presumed route of transmission for both males and females is via
coitus. The preputial cavity and urethral orifice of the penis have been identified as sites most
likely to harbor bovine trichomonads in the bull, but trichomonads do not generally cause
epithelial destruction in these locations. (Parsonson et al., 1974) This may explain why males fail
to develop clinical signs and serve as silent carriers of bovine trichomonosis. Females also
contract T. foetus via sexual intercourse and may go on to develop vaginitis, endometritis and
suffer infertility from about 6-7 weeks on following infection. (Parsonson et al., 1976) If cows
are able to conceive, loss of the fetus may result from early embryonic death or, less commonly,
abortions. Loss of the embryo or fetus most often occurs within the first third to half of
pregnancy. (Rhyan et al., 1988) Clinical signs of infection, as well as evidence of histopathologic
lesions, do not develop until about 2 months post infection in cows with trichomonosis.
(Parsonson et al., 1976) Pyometra has also been described as a rare side effect of venereal
trichomoniasis.
Identification of T. foetus throughout cattle in the United States, (BonDurant et al., 1990;
Goodger and Skirrow, 1986; Skirrow, 1987) Spain (Martin-Gomez et al., 1998; Mendoza-Ibarra
et al., 2012) and Argentina (Mancebo et al., 1995) re-classified bovine trichomonosis as a
globally emerging reproductive pathogen with prevalence rates ranging from 4-30%. Given that
bulls are often asymptomatic carriers, it is possible for one bull to infect many heifers, resulting
in profound losses for the cattle industry. (Goodger and Skirrow, 1986) Some reports document
3

that up to 42% of heifers became infected within a year following exposure to T. foetus positive
bulls (Clark et al., 1983), and that up to 40% of cows lost calves to embryonic abortions. (Clark
et al., 1986) Monetary losses due to trichomonosis in herds practicing natural breeding
techniques were estimated to be as high as $70,000 per herd over an 18 month period from 1985
to 1986 in the United States. (Goodger and Skirrow, 1986)
Initial attempts at preventing transmission within herds included culling infected bulls
and/or cows that failed to become pregnant following breeding (Mancebo et al., 1995), as well as
strict use of younger bulls given that prevalence rates were lower in comparison to older males.
(Christensen et al., 1977) As it became an established belief that cows failed to maintain active
infections past 90 days due to self-limiting infection, some farms implemented a policy of at
least 3 months “rest” in between the next breeding. (Mancebo et al., 1995) Artificial
insemination became adopted as the method of choice to decrease transmission. As no
efficacious preventatives (e.g. vaccines) existed, minimizing transmission by identifying infected
animals was pivotal in minimizing disease spread and halting reproductive losses. Thus, the need
for understanding cytopathogenicity and developing improved diagnostic and preventative
techniques were imperative.
Surface Proteins Identified as Integral in Facilitating Adhesion in Trichomonad Species
The ability of trichomonads to successfully attach to host epithelial cells is one of the
most important inciting events for the exertion of cytopathogenicity. This event requires surface
proteins (e.g. glycoproteins, extra-cellular matrix [ECM] binding molecules and other surface
adhesins) on both the pathogen and host epithelial cell (Bonilha et al., 1995; Silva-Filho et al.,
2002), as well as motile, viable trichomonads capable of utilizing the posterior flagellum as an
4

initial anchor. (Singh et al., 1999; Tolbert et al., 2013) Several molecules are crucial in mediating
adhesion, including glycoproteins, which have been identified as important in facilitating
adhesion of many protozoa species to the host epithelium. Multiple adhesins (i.e. AP65, AP51,
AP33 and AP23) have been recognized as integral in mediating adhesion-dependent cytotoxicity
exerted by Trichomonas vaginalis towards vaginal epithelial cells. (Alderete and Garza, 1988;
Arroyo et al., 1995) Many factors seem to play a role in the mobilization of these adhesion
proteins to the surface of the protozoa, including the presence of an iron-rich environment. It has
been shown that in the absence of iron, T. vaginalis isolates were unable to mobilize these
adhesins to the surface of the protozoa, and were subsequently unable to attach to vaginal
epithelial cells. (Lehker et al., 1991) Additionally, differing phenotypic expression of T.
vaginalis surface adhesins has been shown to occur between isolates and differing passage
numbers. (Alderete and Garza, 1988) The underlying etiology of these phenotypic differences or
shifts has not been fully elucidated, but could explain why some hosts are not as susceptible to
clinical infections as others.
Binding to glycoproteins and proteoglycans in the host ECM complex have been shown
to facilitate both adhesion to host cells as well as initiate a morphologic shape change of the
parasite. (Petropolis et al., 2008) This change transforms the protozoa from its natural “teardrop”
shape to an elongated, amoeboid form, and has been noted in both T. vaginalis (Crouch and
Alderete, 1999) and T. foetus (Petropolis et al., 2008) following interaction with ECM binding
proteins. It has been hypothesized that this morphological change may also upregulate cytotoxic
mediators (e.g. cysteine proteases), but the full significance of this transformation has not been
completely elucidated.
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Another surface complex that has been identified in many protozoa, but may vary greatly
between species, is the lipophosphogylcan (LPG) complex. The LPG complex has been
identified to be composed of a rich matrix of carbohydrates and phospholipid anchors, and is
recognized as the most abundant surface complex in both T. vaginalis and bovine T. foetus.
(Singh, 1993, 1994; Singh et al., 2001) The LPG complex in T. vaginalis, but not bovine T.
foetus, has also been identified as an important molecule mediating not only adhesion to, but
upregulation of proteases that induce cytotoxicity to host epithelial cells. (Fichorova et al., 2006)
While we know that the LPG complex is present in high numbers in bovine T. foetus, ongoing
work is needed to further classify the role of this complex and how it both resembles and differs
from that of the T. vaginalis LPG.
Lastly, some molecules that act to facilitate adhesion in trichomonad species may
actually hamper or diminish adherence to host cells in others. Sialic acid (i.e. carbohydrate)
residues on the surface of host epithelial cells are an example of such a molecule. Presence of
such residues have been shown to facilitate adhesion following interaction with lectin molecules
in bovine T. foetus, while abrogating adhesion in T. vaginalis. (Bonilha et al., 1995) Differing
roles of surface complexes reinforces that ongoing research is necessary to fully understand the
significance of different molecules between species and genotypes.
Diagnostic Tests for Bovine Trichomonosis
Microscopic identification of motile trichomonads served as the first assay for diagnosis
of bovine trichomonosis and was used to confirm the presence of protozoa in herds of beef cattle
in Australia. (Clark et al., 1974; Dennett et al., 1974; Parsonson et al., 1974) Following
development of culture methods found to support in vitro isolation and propagation of several
trichomonad species (Diamond, 1957), in vitro culture of preputial swabs with microscopic (i.e.
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morphologic) identification became the preferred method for diagnosis of bovine T. foetus.
(BonDurant et al., 1990) A significant problem with this technique was a lack of specificity for
T. foetus, as the media also supported growth of other protozoa. An important diagnostic
breakthrough for bovine trichomonosis was the development of a commercially available pouch
culture system (In-Pouch™ TF Culture, Bio Med Diagnostics), which subsequently became
recognized as the most sensitive and specific method for diagnosis of bovine trichomonosis.
(Schonmann et al., 1994) It was found that six serial weekly cultures from preputial samples
yielded a sensitivity of 80-96% and specificity of up to 96% (Hoevers et al., 2003; Parker et al.,
2003a; Parker et al., 2003b), with these percentages fluctuating depending on the exact method
of sample collection and culture conditions (i.e. collection media, transport media, temperature
and storage conditions). (Parker et al., 2003b; Skirrow et al., 1985) The In-Pouch™ culture soon
became the gold standard for diagnosis of bovine trichomonosis.
Unfortunately, this system still relied on visual identification based on morphological
characteristics and the incorrect assumption that the media would result in only T. foetus growth.
The In-Pouch™ culture was subsequently found to also support the growth of other trichomonad
species (i.e. Tetratrichomonas spp., Pentatrichomonas hominis and Pseudotrichomonas spp.)
from the urogenital tract of cattle. (Dufernez et al., 2007) Several studies have demonstrated lack
of specificity of the In-Pouch™ culture, including the growth of presumable gastrointestinal
trichomonads from virgin bulls. (Campero et al., 2003) These findings revealed a lower
specificity of the In-Pouch™ TF culture than originally thought, which in turn spurred
development of more sensitive and specific diagnostics.
Polymerase chain reaction (PCR), using either single or pooled preputial samples from
bulls, has now surpassed the In-Pouch™ TF culture system as a gold standard diagnostic and has
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been used either alone or in conjunction with culture. (Cobo et al., 2007; Felleisen, 1997; Garcia
Guerra et al., 2014; Garcia Guerra et al., 2013; Ho et al., 1994) One study found that three serial
weekly cultures with PCR, performed in parallel, had equivalent sensitivity and specificity to
that of six weeks of culture alone. (Cobo et al., 2007) In a study evaluating the specificity of a T.
foetus PCR, only T. foetus, but not other trichomonad species, was found to amplify (Dufernez et
al., 2007), confirming a specificity of 100% for this technique. With proper sample handing and
performance by experience diagnosticians, the excellent specificity of PCR has been found to be
repeatable across laboratories (Garcia Guerra et al., 2014). Several PCR assays have been
developed for reliable detection of bovine T. foetus, and detect DNA from as little as 1 organism
per 1 mL sample from cell lysate (McMillen and Lew, 2006) or clinical specimens (i.e. smegma
from infected bulls). (Felleisen et al., 1998) Furthermore, assays with an internal validity control
have helped to eliminate false negatives due to insufficient sample size or failed amplification.
(Grahn et al., 2005) As a result of these diagnostic advancements, PCR is now recognized as the
gold standard assay for diagnosis for bovine trichomonosis, either alone or in conjunction with
culture. Repeat serial assays are recommended to increase both sensitivity and specificity.
Discovery of such specific diagnostic testing subsequently shaped the development of feline T.
foetus-specific assays as well.
Discovery of Feline Trichomonosis
Years following the recognition of bovine trichomonosis as an established venereal
pathogen of cattle, another protozoa was identified in the distal intestine of domestic cats
suffering from diarrhea of large bowel origin. Although feline trichomonosis was initially
recognized in Europe, the first published reports of T. foetus as an emerging feline enteric
pathogen followed culture of trichomonads from the distal ileum, cecum and colon of clinically
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affected domestic cats in the United States. (Gookin et al., 1999; Gookin et al., 2001; Levy et al.,
2003) These protozoa were harvested from the feces of cats suffering from foul, waxing and
waning diarrhea. Many of these cats also suffered a similar constellation of clinical signs,
including tenesmus, hematochezia, dyschezia, fecal incontinence, flatulence, and a prominent,
swollen anus. (Gookin et al., 1999) Infection of specific pathogen-free cats with T. foetus
produced similar, albeit less severe, clinical and histopathologic disease of that seen in naturally
infected cats, (Gookin et al., 2001), confirming T. foetus as a feline enteric pathogen. Cats
suffering from trichomonosis are often mis-diagnosed with giardiasis, (Gookin et al., 1999), and
while diarrhea may improve with paromomycin or metronidazole, these treatments often fail to
completely clear infection. Moreover, time to resolution of diarrhea for cats with failed antiprotozoal therapy is longer than for cats who naturally clear infection. (Foster et al., 2004)
Although infected cats often present with Giardia spp. or Pentatrichomonas hominis (P.
hominis) co-infections, cats from which P. hominis alone is cultred do not have the same
diarrhea. Standard anti-protozoal therapy (e.g. metronidazole and fenbendazole) is also usually
recognized to clear diarrhea associated with giardiasis (Levy et al., 2003), but as mentioned, fails
to permanently clear diarrhea associated with T. foetus. Younger, purebred cats and animals in
densely crowded environments (e.g. shelters, catteries and cat shows) have been identified as
more commonly affected. (Burgener et al., 2009; Gookin et al., 1999; Gookin et al., 2004) The
observation of an increased disease prevalence in cats that are in close contact with each other
suggests that feline T. foetus is transmitted via fecal-oral spread. In reports documenting
experimental infection of cats with T. foetus via an orogastric route, cats developed clinical signs
and their feces were PCR positive within 7-14 days of inoculation. (Gookin et al., 1999; Gookin
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et al., 2006) Collectively, this information provided evidence that T. foetus is an enteric pathogen
of domestic cats and should be differentiated from other feline intestinal protozoa.
Lack of a Sensitive and Specific, Point of Care Diagnostic Test for Feline T. foetus
Similar to bovine trichomonosis, feline T. foetus was first identified based on
morphological characteristics via wet mount direct microscopy. This technique is neither
sensitive nor specific given feline T. foetus microscopically resembles both Giardia spp. and
Pentatrichomonas hominis. The In-Pouch™ TF culture (Bio-Med Diagnostics) was the first
method to reliably culture feline T. foetus from fecal samples of diarrheic cats. The commercially
available culture system has an improved sensitivity when compared to wet mount cytologic
diagnosis (i.e. 55% versus 14%, respectively), but false negatives and positives are still possible.
False negatives often occur following inoculation of too much fecal material into the pouch,
resulting in bacterial overgrowth that hampers growth of trichomonads. Although rare, the InPouch™ TF culture has also been reported to support positive growth of other trichomonad
species. (Ceplecha et al., 2013) Additionally, growth of the organisms can take days to even
weeks and must be performed in a laboratory setting. Therefore, culture techniques are not useful
for clinic use for practicing veterinarians to rapidly differentiate cats infected with T. foetus from
those infected with other protozoal pathogens (i.e. Giardia or Pentatrichomonas hominis). For
this reason, more specific, sensitive, and rapid diagnostic tests are recommended for the
diagnosis of feline trichomonosis
Similar to bovine trichomonosis, PCR subsequently became the most sensitive and
specific test for identification of feline T. foetus, and is currently considered the gold standard for
diagnosis of feline trichomonosis. One study demonstrated that nested PCR required the
presence of only 50-500 T. foetus organisms/gram of feces for 100% sensitivity when samples
10

were handled and processed appropriately. (Gookin et al., 2002) This same study showed that
when performed following in vitro culture, PCR increased the chance of a positive diagnosis by
20% compared to either technique alone. Here, fresh feces were cultured at the time of sample
acquisition and deemed as a positive or negative based on in vitro culture in modified Diamond’s
medium. Remaining feces were stored at -70°C until subsequent PCR processing, with samples
for PCR all taken from the original feces rather than fecal culture.
Although PCR has greatly improved the ability of veterinarians to correctly diagnose
feline T. foetus, the method is not without limitations. One such limitation is that this assay
should only be performed by experienced diagnosticians at a properly equipped laboratory, and
can take days for the return of definitive results. Given that PCR is not a patient-side assay, it
hampers the ability of veterinarians to rapidly and accurately diagnose a cat with T. foetus
infection on site. While waiting for the return of results, some cats are given oral therapies that
are inappropriate for the treatment of trichomonosis (i.e. metronidazole) that may also put them
at additional unnecessary risk for drug side-effects. As feline T. foetus is presumably spread via
fecal-oral transmission, identification and isolation of affected cats is recommended. This
underscores the importance of rapidly and accurately identifying infected animals and removing
them from the general population. An in-clinic diagnostic assay would allow veterinarians to not
only identify infected cats, but to also avoid misdiagnosis with non-T. foetus species and to
diminish initiation of inappropriate or unwarranted therapies.
Lack of Safe, Efficacious Therapeutics for Feline T. foetus Infection
As both awareness of and diagnostics for feline trichomonosis began to improve, feline T.
foetus was identified in diarrheic cats throughout Europe, and is now recognized worldwide as a
feline enteric pathogen. (Bissett et al., 2008; Bissett et al., 2009; Burgener et al., 2009;
11

Dabrowska et al., 2015; Miro et al., 2011) The combination of an increased prevalence rate (i.e.
up to 31% in densely crowded environments) (Gookin et al., 2004; Paris et al., 2014), lack of
preventatives and worldwide recognition of feline trichomonosis has led to investigation of antiprotozoal agents that may eradicate infection.
One of the earliest drugs utilized for attempted therapy for feline trichomonosis was
paromomycin, an aminoglycoside used for the treatment of trichomonosis in humans (i.e. T.
vaginalis), but reported to have poor gastrointestinal absorption. (Foster et al., 2004; Gookin et
al., 1999; Poppe, 2001; Tayal et al., 2010) Paromomycin has mixed efficacy in eradicating
diarrhea and clearing feline T. foetus infections, evidenced by positive cultures following
therapy. (Gookin et al., 1999) Although some cats do have a clinical response to this drug, the
time to resolution of diarrhea was actually extended in comparison to cats who naturally clear
infection (Foster et al., 2004) and the drug carries risk of producing acute renal failure and
deafness. (Gookin et al., 1999)
Drugs of the 5-nitroimidazole class were next to undergo investigation as potential
therapies, given their precedential use in human trichomonosis and success in eradicating other
protozoal pathogens. (Upcroft et al., 2006) Their proposed mechanism of action is to create DNA
damage secondary to production of free radical, toxic anions due to a competitive inhibition of
hydrogenase by nitro groups in the hydrogenosome. (Kulda, 1999) Metronidazole (MDZ) is a 5nitroimidazole drug that is recognized as an accepted therapeutic agent for giardiasis in
companion animals. (Scorza and Lappin, 2004; Zimmer, 1987) Unfortunately, feline T. foetus
isolates have been documented as resistant to MDZ in vitro, (Gookin et al 2006) and many
infected cats have no resolution of clinical signs following MDZ therapy. The mechanism of
action of metronidazole resistance is thought to be a mutation in or absence of a normally
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functioning pyruvate: ferredoxin oxioreductase pathway found in resistant trichomonads
(Cerkasovova et al., 1984), as well as utilization of oxygen in microaerophilic environments to
outcompete the drug for bound electrons. (Kulda, 1999) Tinidazole (TDZ), another 5nitroimidazole drug, was initially shown to be effective at preventing replication of T. foetus
isolates in vitro, as well as successfully producing negative cultures during treatment of
experimentally-infected specific pathogen free kittens. (Gookin et al., 2007) However, TDZ is
not recommended as a treatment for feline trichomonosis as many cats relapsed following the
withdrawal of therapy. (Gookin et al., 2007)
To date, there are no approved drugs shown to effectively clear feline T. foetus in all
infected cats. Ronidazole, also of the 5-nitroimidazole class, is the only therapeutic agent now
utilized for off-label treatment of feline T. foetus infection. Ronidazole, also of the 5nitroimidazole class, is the only therapeutic now utilized for off-label treatment of feline T.
foetus infection. (Gookin et al., 2006) Unfortunately, multiple problems have been identified
with the use of ronidazole as a therapeutic agent. Firstly, development of neurologic
abnormalities (e.g. nystagmus, ataxia and mentation changes) have been documented following
oral administration to infected cats. (Rosado et al., 2007) The risk of neurotoxicoses is thought to
increase with twice daily dosing of > 30 mg/kg (Rosado et al., 2007), and twice-daily dosing is
no longer recommended due to concern for a long half-life and plasma accumulation of the drug
following twice daily administration. (LeVine et al., 2014; LeVine et al., 2011) Although lower
doses (i.e. 10 mg/kg twice daily) have not been documented to initiate adverse effects, they are
ineffective at clearing infection. (Gookin et al., 2006) Secondly, in addition to the risk of
unacceptable adverse effects, both in vitro and in vivo aerobic resistance of feline T. foetus
isolates to ronidazole has been recognized. (Gookin et al., 2010) Though the true prevalence of
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T. foetus resistance to ronidazole is unknown, documentation of in vitro resistance and failure to
resolve clinical signs in naturally infected cats is evidence that ronidazole is less than ideal for
treatment of this disease in cats. Increasing resistance, risk of adverse effects and the lack of
suitable alternatives to ronidazole makes it so that no safe, completely efficacious therapeutics
exist for treatment of feline trichomonosis. Therefore, there is a need for improved diagnostic,
therapeutic and/or preventative strategies for feline T. foetus infection.
Classification of Bovine and Feline T. foetus in Regards to Organ Tropism
Before development of a novel diagnostic or therapeutic, an initial marker must be
identified that is present in all feline T. foetus isolates and either easily identifiable for the
purposes of an assay or accessible to any drugs targeting it. In an attempt to understand more
about shared pathogenic mechanisms between T. foetus genotypes, multiple comparative analysis
studies have been performed to classify the similarities and differences between bovine and
feline T. foetus. (Slapeta et al., 2010; Slapeta et al., 2012; Sun et al., 2012) From these analyses,
two main theories have been proposed as to the most appropriate classification system. One
current belief is that bovine and feline T. foetus are of the same trichomonad species, but
represent two distinct genotypes. This is based on work that has identified groups of feline and
bovine isolates as 100% similar to each other when comparing multiple isolates from the same
host species (i.e. all genes of feline isolates are 100% similar and all genes of bovine isolates are
100% similar), but consistently found differences in transcriber regions between species.
(Slapeta et al., 2010; Slapeta et al., 2012) These differences in transcriber regions include a
repeatable polymorphism in the ITS-2 region (Slapeta 2010), as well as several nucleotide
mutations resulting in amino acid differences between bovine and feline T .foetus cysteine
protease (CP) genes (i.e. CP2, CP4, CP5 and CP8). (Slapeta et al., 2012) The significance of
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these differences remains unknown. A second theory proposes that feline T. foetus is an entirely
different species than bovine T. foetus and should be recognized as a separate entity (i.e.
Tritrichomonas blagburni spp.). This is based on work investigating similarities and differences
between bovine and feline tritrichomonas isolates when comparing highly conserved ribosomal
DNA gene sequences, which are 97-100% similar between not only bovine and feline isolates,
but also between T. foetus, T. suis and T. mobilensis. The argument for this latter theory is that if
bovine T. foetus is classified as a separate species from porcine and/or simian trichomonads,
feline tritrichomonads should also be recognized as a new species given there is the same amount
of genetic diversity between these protozoa. (Walden et al., 2013)
Several studies have shown that there are also discrepant degrees of cytotoxicity towards
host epithelial cells following trans-species infections (e.g. infection of cattle with feline T.
foetus isolates, and vice versa). Although cytotoxicity to vaginal epithelial cells is histologically
evident following infection of cattle with feline T. foetus, the bovine urogenital epithelium does
not display the same degree of inflammatory infiltrates or destruction of the uterine glands as is
seen when cattle are infected with their natural host genotype. (Stockdale et al., 2007) Similarly,
when cats were experimentally infected with bovine T. foetus, the protozoa did not achieve the
same degree of colonization or induce equivalent cytotoxicity to host intestinal epithelium as is
seen following experimental infection of cattle. In this same study, only one cat cultured positive
for the protozoa weeks after infection and the bovine isolates failed to colonize the distal ileum
and colon as is seen with natural infection of felines. (Stockdale et al., 2008) It was also found
that bovine T. foetus was cleared much more rapidly from the feline alimentary tract than cats
infected with feline isolates. (Stockdale et al 2007) This suggests that the genotypes may have
specific tolerances or adaptations to their host environments regardless of similarities in genomes
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or transcriptomes. Although some feel these differences in trans-species infections support the
theory that feline and bovine genotypes are two different species, experimental infection of cats
with feline T. foetus isolates fails to result in the same degree of inflammatory damage to the
epithelium seen with natural infection. (Gookin et al., 2001; Yaeger and Gookin, 2005)
Therefore, any differences in histopathology from trans-species infection may result from
experimental infection alone, rather than indicating a need for delineation into separate species.
Interestingly, earlier studies investigating the transmission of bovine trichomonosis
demonstrated that when T. foetus cultures were applied directly to the vulva instead of the
vagina, infection was not established. (Clark et al., 1977) This may suggest that bovine T. foetus
lacks de-adhesins necessary to migrate from the vulva up into the vagina for colonization.
Although a fecal-oral route of transmission for feline trichomonosis has only been hypothesized
and not proven, it makes sense feline T. foetus would require a mechanism of de-adhesion or deattachment from host epithelium, whereas bovine T. foetus may only require mechanisms
facilitating attachment to epithelial cells following direct deposition into the vaginal vault.
Some of the proposed phenotypic differences between bovine and feline trichomonads
include not only possible functional differences between similar adhesins or surface markers, but
differences in pH tolerance as well. Recent work has looked at viability of both bovine and feline
trichomonads in response to a gradient of buffered pH between 6 and 8. (Morin- Adeline et al
2015). Feline trichomonads displayed a higher tolerance for acid buffering/resistance than bovine
trichomonads in this study, suggesting differences in phenotypes depending on host niche.
Collectively, these studies support hypotheses that there is host specificity in regards to degree of
infectivity, which is evidenced by distinct organ tropism.
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Bovine and Feline T. foetus Share Virulence Factors
Although bovine and feline T. foetus are classified as two distinct genotypes, conserved
virulence mechanisms have been identified. This may be unsurprising given the large amount of
homology seen between bovine and feline sequences, with only a 1% total nucleotide divergence
found in the available genome. (Reinmann et al., 2012; Slapeta et al., 2012) Cysteine proteases
(CPs) have been identified as integral in not only directly promoting adhesion of the protozoa to
epithelial cells, but upregulating the release of substances cytotoxic to the epithelium. Following
analysis of 10 different genetic loci representing cysteine proteases, only a 1% difference was
found between feline and bovine T. foetus for all 10 genes. (Slapeta et al., 2012) Of particular
interest is the homology found between genotypes in CP8 (also called CP30), which has already
been identified as highly expressed (Mallinson et al., 1995) and an integral virulence factor in
bovine T. foetus cytopathogenicity. (Lucas et al., 2008) It has not only been shown that bovine
trichomonads utilize CP30 in order to exert adhesion-dependent cytotoxicity towards epithelial
cells, but that the use of cysteine protease inhibitors abolishes T. foetus-induced destruction of
urogenital epithelium. (Singh et al., 2005) Because CP8/CP30 was first identified as important in
the pathogenesis of bovine T. foetus, the next logical step was to look for conservation of this
protease feline isolates. Two single nucleotide polymorphisms have been identified in CP8
between T. foetus species, which are not thought to be in the functional region of the gene. (Sun
et al., 2012) The polymorphisms are of unknown significance at this time, but perhaps have a
role in phenotypic differences seen between genotypes in terms of organ tropism between cattle
and domestic cats. Other recent analyses comparing bovine and feline genotypes have revealed a
large amount of homology between their functional transcriptomes. (Morin-Adeline et al., 2014)
Moreover, recent work has also established that cysteine proteases are as important in mediating
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adhesion-dependent cytopathogenicity in feline T. foetus as they are in bovines. This same study
also demonstrated that the use of broad spectrum cysteine protease inhibitors had an ameliorative
effect on destruction of host intestinal epithelial cells by feline T. foetus. (Tolbert et al., 2014)
Thus, it is reasonable to conclude that cysteine proteases represent major virulence factors for
both bovine and feline T. foetus by facilitating both adhesion and cytotoxicity to respective host
epithelial cells.
As already mentioned, the lipophosphoglycan complex has been identified in most
protozoa and thought to help mediate adhesion to the host epithelium. Further studies are needed
to determine if feline T. foetus also possess an LPG complex, but conservation of this complex
seems likely given its identity has already been determined to be conserved across multiple
protozoa (i.e. bovine T. foetus, T. vaginalis and Leishmania spp. (Singh, 1993; Turco, 1988)).
Further work is necessary to determine exactly which CPs are utilized by feline T. foetus,
as well as if other surface proteins important to adhesion are conserved between genotypes.
Given the similarities seen thus far between T. foetus genomes and transcriptomes, bovine
trichomonosis represents a reasonable model in searching for novel diagnostic or therapeutic
targets for feline T. foetus.
Surface Antigen 1.15-1.17 Found to Participate in Bovine T. foetus Adhesion and
Complement Mediated Killing
As previously mentioned, several groups have shown that bovine T. foetus utilizes
surface glycoproteins to mediate attachment to mammalian host cells. One of these is the bovine
T. foetus 190 (Tf190) glycoprotein, which has been classified as part of the T. foetus
lipophosphoglycan (LPG) group. Inhibition of Tf190 with monoclonal antibodies has been
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shown to inhibit the ability of bovine trichomonads to adhere to bovine urogenital epithelial
cells. (Burgess and McDonald, 1992) Similarly, a distinct bovine T. foetus surface glycoprotein
was also found to mediate adhesion of the protozoa to bovine epithelial cells. The antigen was
originally classified as a glycoprotein based on thymol staining and diffusely migrating nature of
the band via immunoblotting, and named 1.15-1.17. (Hodgson et al., 1990) It was proposed that
two epitopes of the surface antigen existed (i.e. 1.15 and 1.17) and demonstrated that treatment
of bovine trichomonads with anti-1.17 and anti-1.15 inhibited T. foetus adhesion to epithelial
cells by up to 73%. (Hodgson et al., 1990) Application of mAb 1.15 also killed bovine
trichomonads in a complement-independent manner, suggesting that these epitopes may have a
role in induction of protective immunity. Importantly, the presence of 1.15-1.17 was found to be
conserved across 37 bovine isolates tested via indirect enzyme-linked immunosorbent assay
(ELISA) (JS et al., 1993), making this antigen an attractive target for development of a novel
diagnostic test or therapeutic agent.
To further test the hypothesis that this antigen has a role in protective immunity, surface
epitope 1.17 was purified and administered as an immunogen to both bulls and heifers which
were subsequently experimentally infected with T. foetus. As hypothesized, vaccination of
heifers with purified epitope 1.17 was found to significantly increase the percentage of cows that
were able to successfully clear vaginal T. foetus infection (80%) when compared to equal
numbers of cows vaccinated with control that had negative cultures at 7 weeks of infection
(37%). (Bondurant et al., 1993) This same study also showed that purified 1.17 stimulated an
immune response via indirect enzyme-linked immunosorbent assay (ELISA) quantification of
IgG in both serum and vaginal secretions. Later work revealed that a local IgA response persisted
in vaginal secretions for up to 24 weeks (Ikeda et al., 1995), and vaccinated heifers had
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significantly less histologic evidence of endometritis compared to non-vaccinated animals who
either failed to clear or took longer to clear the infection. (Anderson et al., 1996) Thus,
immunization with purified 1.17 was shown to improve clearance of T. foetus, diminish
endometritis and reduce rates of fetal loss and infertility.
The relationship between 1.15-1.17, Tf190 and the previously discovered LPG complex
was also examined via ELISA and western blotting. Monoclonal antibodies 1.15 and 1.17 were
tested for reactivity with purified Tf190, epitope 1.17 and LPG. All three antigens were positive
for reactivity with both mAbs, lending evidence to the fact that 1.15-1.17 likely belongs to this
larger family of lipophosphoglycans with an integral role in mediating adhesion of bovine
trichomonads to host urogenital epithelium. (Singh et al., 2001)
Lastly, the presence of epitope 1.15 in feline T. foetus isolates has been evaluated by
several different groups. Combining the results of several different studies, a total of 8 feline
isolates from experimentally infected cats (Gookin et al., 2001) and 10 feline isolates from
naturally infected cats (Gookin et al., 2010; Gray et al., 2010; Yaeger and Gookin, 2005) were
shown as positive for the surface epitope 1.15. An additional 3 feline isolates were found
positive for epitope 1.15, although the source of these isolates (i.e. from experimentally or
naturally infected cats) was not specified. (Corbeil et al., 2008) All studies utilized the same
ascitic fluid mAb 1.15 from the original studies with cattle (Hodgson et al., 1990), except for one
which utilized a polyclonal anti-TF1.15 antibody. (Gray et al., 2010) No studies to date have
investigated for the presence of epitope 1.17 in feline T. foetus, nor evaluated for antigen 1.151.17 in other trichomonads that infect cats (e.g. Pentatrichomonas hominis [P. hominis]).
Evaluation of feline intestinal trichomonads for continued conservation of 1.15, the presence of
epitope 1.17 and any role this antigen may play in mediating feline T. foetus cytopathogenicity is
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warranted. If 1.15-1.17 is not present in feline P. hominis and/or aides in cytopathogenicity, it
may represent an excellent novel diagnostic or therapeutic target for feline trichomonosis.
Although multiple protective surface proteins and/or epitopes have been identified as
potential targets for a key role in initiating a protective immune response, epitope expression
may differ between isolates and even between different in vitro passage numbers of the same
isolate. (Hodgson et al., 1990; JS et al., 1993) Further investigation of factors mediating
heterogeneous levels of expression are necessary in order to understand how best to utilize these
molecules as preventative, diagnostic and/or therapeutic targets.
It is reasonable to propose that antigen 1.15-1.17 may represent a novel diagnostic or
therapeutic target for feline trichomonosis if epitope 1.17 is conserved across feline T. foetus
isolates and/or the function of this antigen in felines contributes to T. foetus adhesion-dependent
cytopathogenicity. Given the similarities identified between virulence factors shared by
genotypes, we propose that surface antigen 1.15-1.17 is also conserved between bovine and
feline T. foetus.
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CHAPTER TWO: IDENTIFICATION AND INVESTIGATION OF
BOVINE TRITRICHOMONAS FOETUS SURFACE EPITOPES
CONSERVED IN FELINE TRITRICHOMONAS FOETUS

ABSTRACT

Tritrichomonas foetus (T. foetus) is a flagellated protozoa that infects the distal ileum and
proximal colon of domestic cats and the urogenital epithelium of cattle. Feline trichomonosis is
recognized as a prevalent cause of large bowel diarrhea in cats worldwide. The suspected route
of transmission is fecal-oral, with cats in densely crowded environments at highest risk for
infection. Thus, the recommended strategy for minimizing spread of infection is to identify and
isolate T. foetus-positive cats from the general population. Rapid and accurate identification of
infected cats can be challenging with currently inadequate ability to accurately detect the
organism in samples at point of care facilities. Thus, identification of targets for use in
development of a novel diagnostic test, preventative, or therapy for feline T. foetus infection is a
significant area of research. Despite a difference in organ tropism between T. foetus genotypes,
evidence exists for conserved virulence factors between feline and bovine T. foetus. The bovine
T. foetus surface antigen, 1.15-1.17, has been identified as an adhesin that is conserved across
isolates. Vaccination with the purified antigen results in amelioration of cytopathogenicity and
more rapid clearance of infection in cattle. We hypothesized that antigen 1.15-1.17 is conserved
across feline T. foetus isolates and that this antigen would represent an attractive target for
development of a novel diagnostic test or therapy for feline trichomonosis. In these studies, we
used monoclonal antibodies previously generated against epitopes of the bovine T. foetus 1.151.17 antigen, to evaluate for the presence and role of antigen 1.15-1.17 in the cytopathogenicity
of feline T. foetus. A previously validated in vitro co-culture approach was used to model feline
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T. foetus infection. Immunoblotting, immunofluorescence assays, and flow cytometric analysis
demonstrated the presence and surface localization of antigen 1.15-1.17 across all feline T.
foetus isolates tested. Antigen 1.15-1.17 was notably absent in the presumably nonpathogenic
intestinal trichomonad, Pentatrichomonas hominis, a parasite that can be confused
microscopically with T. foetus. In contrast to bovine trichomonosis, antigen 1.15-1.17 did not
promote T. foetus adhesion to or cytopathogenicity towards the intestinal epithelium in an in
vitro model. Although a porcine, rather than feline, in vitro intestinal epithelial cell line was
utilized for all co-culture assays, these results support further investigation of protein 1.15-1.17
as a target for the diagnosis of feline T. foetus infection.
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Introduction
Tritrichomonas foetus (T. foetus) is a protozoal pathogen responsible for chronic diarrhea
in domestic cats as well as reproductive failure (i.e. infertility, abortions and early embryonic
death) in cattle. Feline T. foetus is a global enteric pathogen with infections recognized in North
America, Europe and Australia, among others. (Bissett et al., 2008; Gookin et al., 2004; GunnMoore et al., 2007; Hosein et al., 2013; Miro et al., 2011; Xenoulis, 2011) The suspected route
of transmission is fecal-oral, with cats in densely crowded environments (e.g. shelters, catteries
and cat shows) at highest risk for infection. Thus, the recommended strategy for minimizing
spread of infection is to identify and isolate T. foetus-positive cats from the general population.
Rapid and accurate identification of infected cats can be challenging, particularly in point of
care facilities, with detection currently limited to fecal smear and In-Pouch™ culture. The
sensitivities of these tests are low, 14 and 55%, respectively (Foster et al., 2004; Gookin et al.,
2003; Gookin et al., 2002) and may be associated with misdiagnosis as a result of the presence
of other intestinal protozoal pathogens that infect cats (e.g. Giardia spp and Pentatrichomonas
hominis). The best available diagnostic test, polymerase chain reaction (PCR), is not an in-clinic
assay at present. Although PCR carries moderately good sensitivity, as long as performed by
experienced diagnosticians (Gookin et al., 2002), results may take up to 2 weeks. Therefore,
PCR may not be a viable option for shelters needing to frequently test suspect cats.
Safe and effective therapies for the treatment of feline trichomonosis are also limited.
Only one drug, ronidazole, is available to treat feline T. foetus infection, but this drug is used
off-label for treatment of cats, has been associated with increasing resistance, and has a narrow
margin of safety, potentially resulting in neurotoxicity. (Gookin et al., 2010; LeVine et al.,
2011; Rosado et al., 2007) Thus, identification of targets for use in development of a novel
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diagnostic test, preventative, or therapy for feline T. foetus infection is a significant area of
research. Despite a difference in organ tropism, bovine and feline T. foetus are genetically
similar and evidence exists for conserved virulence factors between genotypes. (Morin-Adeline
et al., 2014; Slapeta et al., 2012; Sun et al., 2012; Tolbert et al., 2014)
The bovine T. foetus surface antigen, 1.15-1.17, has been identified as an adhesin that
promotes parasite attachment to the urogenital epithelium (Hodgson et al., 1990). This surface
antigen, later identified to be part of the T. foetus lipophosphoglycan (LPG) complex, was found
to be conserved across 37 bovine isolates tested. (Ikeda et al., 1993; Singh et al., 1994)
Treatment of bovine T. foetus with monoclonal antibodies directed against epitopes of the 1.151.17 antigen significantly reduced adhesion of bovine T. foetus to bovine vaginal epithelial
cells. (Hodgson et al., 1990) Given the similarities previously identified between the two
genotypes, we hypothesized that feline T. foetus also express antigen 1.15-1.17, which, based on
the findings for bovine T. foetus, may represent a novel diagnostic and therapeutic target for
feline trichomonosis.
In these studies, we used monoclonal antibodies previously generated against epitopes of
the bovine T. foetus 1.15-1.17 antigen, to evaluate for the presence and role of antigen 1.15-1.17
in feline T. foetus. Our results suggest that antigen 1.15-1.17 is present in all feline T. foetus
isolates tested (n=12). Moreover, antigen 1.15-1.17 is notably absent in P. hominis, a
nonpathogenic intestinal trichomonad that can be confused for T. foetus. In contrast to bovine
trichomonosis, 1.15-1.17 does not promote T. foetus adhesion to or cytopathogenicity towards
intestinal epithelium in this in vitro model. While these results suggest this antigen may not be a
useful target for treatment of this infection in cats, our data does support further investigation of
antigen 1.15-1.17 as a target for the diagnosis of feline T. foetus infection.
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Materials and Methods

Feline T. foetus isolates: Twelve axenized feline T. foetus isolates (Isolates A, B, C, D,
F, Ja, JT, K, Ma, Mo, Sta and Sti) were used for all assays to account for variability amongst
trichomonads. Isolates were harvested at the University of Tennessee and North Carolina State
University from fecal samples obtained from naturally infected cats geographically distributed
throughout the USA. Passage numbers 3-10 were used for all assays. An isolate of the
nonpathogenic feline intestinal trichomonad, Pentatrichomonas hominis, harvested from the
feces of a naturally infected cat, and two bovine T. foetus isolates, one from industry (American
Type Culture Collection [ATCC®], Manassas, KS) and one isolated from a naturally infected
bull from Auburn University (Aub), were used in all assays. P. hominis and bovine T. foetus
isolates served as negative and positive controls, respectively. As only one P. hominis isolate
has ever been harvested from a naturally infected cat, this was the only negative control isolate
utilized. All isolates were cultivated as previously described. (Gookin et al., 2001; Tolbert et al.,
2012) Bovine T. foetus isolates were donated from Dr. Rebecca Wilkes (University of
Tennessee) and Dr. Chance Armstrong (Auburn University).

IPEC-J2 cells: The porcine jejunal epithelial cell line (IPEC-J2), a non-transformed
primary cell line originally isolated from neonatal piglet jejunum, was cultured as previously
described. (Tolbert et al., 2014; Tolbert et al., 2013) This line was obtained as a gift from Helen
M. Berschneider. Briefly, IPEC-J2 monolayers were cultivated in culture media that included
Advanced Dulbecco’s Minimal Essential Medium: Nutrient Mixture F-12 (DMEM/F12)
supplemented with 5 g/ml each of insulin, transferrin, and selenium, EGF (5 ng/ml), penicillin
(50,000 IU/ml), streptomycin (50,000 mg/ml) and 5% fetal bovine serum and incubated at 37°C
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in 5% CO2. All cell culture reagents were supplied by Thermo Fisher Scientific (Thermo
Scientific, Rockford, IL). Prior to co-culture studies with feline T. foetus isolates, IPEC-J2 were
seeded on 24-well polystyrene plates and allowed to reach confluence as previously described.
(Tolbert et al., 2014; Tolbert et al., 2013) Immediately prior to infection studies, culture media
was replaced with co-culture media, which contained the same constituents as culture media but
was devoid of serum to prevent replication of trichomonads and epithelial cells during infection
studies. Uninfected IPEC-J2 monolayers and monolayers infected with isotype control
(unlabeled mouse IgG; Southern Biotech, Birmingham, AL)-treated T. foetus were used as
negative and positive controls, respectively, for all co-culture assays using mAb-treated T.
foetus. IPEC-J2 cells were used at passage numbers 45-61.

Monoclonal antibodies: Monoclonal antibodies (mAbs) targeting bovine T. foetus surface
epitopes 1.15 and 1.17, kindly provided by Dr. Bibhuti Singh (Upstate Medical University), were
used for all assays. Both mAbs had been prepared via standard methods using hybridomas
prepared with splenocytes from BALB/c mice immunized with 0.8 x 106 live bovine
trichomonads. (Hodgson et al., 1990) All antibodies were stored as aliquots at -20°C to prevent
antibody degradation from repetitive freezing and thawing.

Western blot: Western blot analysis was used to evaluate for the presence of bovine T.
foetus epitopes 1.15 and 1.17 in feline T. foetus isolates. Trichomonads at mid-logarithmic
growth phase were washed twice with 1X Dulbecco’s Phosphate Buffered Saline (DPBS), lysed
in 400 µL radioimmunoprecipitation assay (RIPA) buffer containing 1X phosphate buffered
saline (PBS) (pH 7.4), 1% IGEPAL, 0.5% sodium deoxycholate and 0.1% sodium dodecyl
sulfate (SDS), then sonicated twice for 15 seconds each prior to incubation for 30 min at 4°C.
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Lysates were centrifuged at 13,793 x g for 10 min at 4°C, with supernatant recovered and
diluted in lithium dodecyl sulfate (LDS) buffer (Novex® by Life Technologies, Carlsbad, CA).
Protein concentrations were determined with a bicinchoninic acid (BCA) assay according to
manufacturer’s instructions (Thermo Scientific, Rockford, IL). Lysates were reduced in SDS
reducing buffer (Novex® by Life Technologies, Carlsbad, CA) and heated at 70°C for 10
minutes prior to SDS-PAGE analysis. Proteins were electrophoretically separated at a voltage of
200V for 45 minutes using 4-12% Bis-Tris gels (Novex® by Life Technologies, Carlsbad, CA),
and transferred to a nitrocellulose membrane at 30V for 60 minutes. Nitrocellulose membranes
were blocked overnight in blocking buffer (Starting Block T20 buffer; Thermo Fisher
Scientific, Rockford, IL) at 4°C. Immunoblotting was performed using the anti-1.15 and 1.17
primary antibodies diluted 1:500 in Tris-Buffered Saline Tween-20 (TBST) for 4 hours at room
temperature (RT) under gentle agitation. Membranes were washed three times with TBST for
15 minutes each under gentle agitation prior to addition of horseradish peroxidase-conjugated
F(ab’)2 goat anti-mouse IgG and IgM secondary antibody (Jackson Immuno, West Grove, PA)
diluted at 1:500 in blocking buffer for 30 minutes at RT. All membranes were washed in TBST
six times for 15 minutes each prior to developing. Immunoblots were exposed to a
chemiluminescent agent for 5 minutes (Thermo Fisher Scientific, Rockford, IL) and evaluated
with ImageQuant™ LAS 4000 software.
Indirect immunofluorescence: Immunofluorescence (IF) was used as an additional
qualitative assay to evaluate for the presence of 1.15 and 1.17 in feline T. foetus isolates. Midlog phase whole organism trichomonads were pelleted at 1500 x g for 5 minutes at RT, washed
once with 1X PBS and re-suspended to 1 x 107 trichomonads/mL in 1XPBS. A hydrophobic
barrier pen (Vector Laboratories, Burlingame, CA) was used to create barriers on slides pre-
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treated for electrostatic adherence (Thermo Fisher Scientific, Rockford, IL) in order to ensure
trichomonads would remain contained to specified areas of the slide. 3 x 106 whole organism
trichomonads were applied to slides pre-treated for electrostatic adherence (ThermoFisher
Scientific) via direct pipetting to areas already denoted by the barrier pen and allowed to adhere
at RT for 1 hour. All samples were fixed in acetone at -20°C for 15 min and then allowed to air
dry for up to 3 minutes. Both adherence and fixation steps were optimized from an original
protocol that utilized a cytospin to adhere trichomonads to slides without a permeabilizing
agent, thus allowing surface localization of the antigen via IF. At centrifugation speeds required
to successfully adhere whole T. foetus to slides, damage to protozoal membranes was observed.
Thus, hand application with fixation was necessary to preserve the shape of trichomonads. As
acetone acts as a simultaneous permeabilizing agent, results of these assays confirmed presence
of antigen but did not distinguish between intracellular and surface localization. Slides were
rinsed briefly in 1X PBS for 5 minutes and incubated for 1 hr at RT in blocking buffer (1X PBS,
5% goat serum and 2% BSA). Slides were then incubated with mAb (1.15 or 1.17) diluted
1:100 in blocking buffer for 3 hours in a humidified chamber at RT. Following incubation with
primary antibody, slides were rinsed three times in 1X PBS for 5 minutes each followed by
incubation in fluorescein isothiocyanate (FITC)-conjugated F(ab’)2 goat anti-mouse IgG and
IgM (Jackson Immuno Research, West Grove, PA) diluted 1:50 in block buffer for 1 hour at
RT. Following three rinses with 1X PBS for 5 minutes each at RT, the nuclear counterstain,
DAPI (i.e. 4’6-diamidino-2phenylindole) (Vectashield, Vector Laboratories, Burlingame, CA)
was applied for visualization of epithelial and trichomonad nuclei. A mercury epifluorescence
microscope (Nikon® Digital Sight DS, Melville, NY) was used for detection of fluorescence.
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Flow cytometry: Flow cytometry was performed for semi-quantitative analysis and
confirmation of surface localization of 1.15-1.17. Trichomonads, harvested at mid-logarithmic
phase of growth, were pelleted at 1500 x g for 5 minutes, washed once in 1X PBS and resuspended to 5 x 106 trichomonads/mL in flow buffer containing 60 mL of 0.5% sodium azide
solution, 87 mL of 1X PBS and 3 mL of fetal bovine serum. This flow buffer preserved
trichomonad membrane structure while preventing permeabilization of the cells, thus allowing
for the detection of epitopes 1.15 and 1.17 on the surface of feline isolates of T. foetus. The use
of microcentrifuge tubes was avoided for all flow cytometric analyses as shear forces from a
microcentrifuge lysed the protozoa, rendering it impossible to evaluate for the presence of
surface antigens. Conical tubes (15 mL) preserved the shape of mid-log phase trichomonads and
were used for all flow assays. Three isolates (A, Sti, Ja) were evaluated for the presence of both
epitopes with flow cytometric analysis. Each isolate was divided into 1 mL aliquots for the
following treatment groups: (1) T. foetus receiving both primary and secondary antibody, (2) T.
foetus receiving only secondary antibody (negative control), and, (3) T. foetus receiving no
antibodies (auto-fluorescence). Isolates were pelleted, and 10 µL of primary mAb, either 1.15 or
1.17, was added to the pellet for a final dilution of 1:100 per 1 mL of re-suspended
trichomonads. All samples were incubated on ice for 30 minutes and washed once with 1 mL of
1X PBS. Fluorescein isothiocyanate (FITC)-conjugated F(ab’)2 goat anti-mouse IgG and IgM
antibody was applied at the same concentration of 1:100 directly to the pellet, incubated for 30
min on ice, washed once more and re-suspended to a final volume of 1 mL in 1XPBS for
analysis. A total of 10,000 events (i.e. trichomonads) were analyzed for each treatment
population, and each isolate was analyzed in triplicate. All data were acquired on an Attune®
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acoustic focusing flow cytometer (Applied Biosystems, Thermo Fisher Scientific, Rockford,
IL).
Adhesion assays: To quantitatively evaluate the effect of epitopes corresponding to
antibodies 1.15 and 1.17 on the adhesion of feline T. foetus to the intestinal epithelium,
adhesion assays were performed using uninfected monolayers and monolayers infected with
isotype control-treated (unlabeled mouse IgG, Southern Biotech, Birmingham, AL) or mAb (i.e.
anti-1.15 or 1.17)-treated T. foetus. Carboxyfluorescein succinimidyl ester (CFSE) (CellTrace™
CFSE cell proliferation kit, Thermo Fisher Scientific, Rockford, IL) was used to fluorescently
label viable trichomonads prior to treatment with antibody or isotype control groups. IPEC-J2
monolayers were cultivated to confluence at a previously established concentration of
approximately 5 x 104 cells/well in 24-well polystyrene plates prior to infection with T. foetus as
previously described. (Tolbert et al., 2014; Tolbert et al., 2013) Immediately prior to infection,
culture media was replaced with co-culture media, which contained the same added ingredients
except serum, to prevent replication of trichomonads and epithelial cells during infection
studies. IPEC-J2 monolayers were inoculated with 10 x 106 T. foetus per well as previously
described (Tolbert et al., 2014; Tolbert et al., 2013), with all trichomonad groups pre-treated
with either 1:100 mAb (anti-1.15 or 1.17) or a volume equivalent to 1 µg unlabeled mouse IgG
per 1 x 106 trichomonads, according to the manufacturers recommendations for a validated
isotype control, prior to infection. IPEC-J2 monolayers were infected with trichomonads
immediately following application of the respective treatment (i.e. antibody or isotype control)
to each group. Any volume differences between the isotype control and mAb-treated groups
were accounted for with addition of DPBS. A third group containing only 1:100 primary
antibody (mAb 1.15 or 1.17) but lacking T. foetus was used as additional control to evaluate for
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non-specific binding of antibody to the IPEC-J2 cells. Infected and uninfected groups of IPECJ2 cells were maintained at 37°C in 5% CO2. After 6 hours of co-culture, an established time for
adhesion based on a previously validated co-culture model (Tolbert et al., 2013), the cells were
washed twice gently with 37°C DPBS and counterstained with DAPI (Vectashield, Vector
Laboratories, Burlingame, CA). Adherent trichomonads in individual wells were counted in six
high power fields (HPFs) using an epifluorescence microscope (Nikon® Digital Sight DS,
Melville, NY), with the average of six HPFs representative of one replicate. Two feline T.
foetus isolates (A, Sti) were utilized for adhesion experiments. Assays were performed with a
minimum of 4 replicate cultures per treatment group and repeated twice for a total of three
experiments per isolate. Mean or median adherence were compared among all groups with
either parametric or nonparametric distributions, respectively.
Crystal violet cytotoxicity assays: To provide a quantitative analysis of the effect of
epitopes 1.15 and 1.17 on T. foetus-induced epithelial cytotoxicity, crystal violet (CV) assays
were performed, as previously described, (Tolbert et al., 2014) using uninfected monolayers and
monolayers infected with isotype control-treated (unlabeled mouse IgG) or 1:100 mAb (i.e.
anti-1.15 or 1.17)-treated T. foetus. Monolayers were infected as described above for adhesion
assays, with the exclusion of labeling with CFSE. After 24 hours of co-culture (time based on
previously established cytotoxicity model), wells were washed twice with DPBS and stained
with crystal violet as previously described. (Tolbert et al., 2014) IPEC-J2 monolayers were
gently washed twice with dH20 and allowed to air dry. Monolayers were immediately observed
by light microscopy using a Nikon inverted light phase-contrast microscope (Nikon® Digital
Sight DS-U3, Melville, NY), then were solubilized in 100 L 1% SDS in 50% ethanol for
spectrophotometric analysis. Solubilized cells were transferred to 96 well plates and the
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intensity of staining was quantified using a spectrophotometer at a wavelength of 570 nM. Two
feline T. foetus isolates (A, Sti) were used for cytotoxicity experiments. Assays were performed
in a minimum of 6 replicate cultures per treatment group and repeated twice for a total of three
experiments per isolate. Spectrometric means or medians were compared among all groups (T.
foetus with or without mAb treatment and uninfected monolayers) for either parametric or
nonparametric distributions, respectively.
Statistical Analysis: Data were analyzed for normality (Shapiro-Wilk) and variance
(Brown-Forsythe) using a statistical software package and tested for significance using parametric
or non-parametric tests as appropriate (Sigma Plot13, Systat Software, Inc.). Parametric data were
analyzed using either a Student’s t-test or one-way ANOVA. Non-parametric data were analyzed
using either a Mann-Whitney rank sum test or Kruskal-Wallis one-way ANOVA on Ranks. When
a significant treatment effect was observed, a posthoc Tukey, Holm-Sidak or Dunn’s test was
performed to determine which groups were significantly different from each other. n = number of
replicates. Results are reported as mean ± standard deviation. For all analyses, P  0.05 was
considered significant.

Results
Both epitopes of bovine T. foetus antigen 1.15-1.17 are present in feline T. foetus
isolates: Western blotting was performed to evaluate for the presence of epitopes 1.15 and 1.17
across multiple feline T. foetus isolates. Protein lysates from all twelve feline and two bovine T.
foetus isolates were found to possess a diffusely migrating band, characteristic of a glycosylated
protein (e.g. lipophosphoglycan complex or glycoprotein), ranging from approximately 36 to 64
kDa following incubation with mAb 1.15 (Fig. 1A). Diffuse bands of approximately the same
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molecular weight were also seen in the same isolates following application of mAb 1.17 (Fig. 1B).
Both epitopes were identified to be absent in P. hominis (Fig. 1A and B). Although equivalent
concentrations of protein lysate, based on the previously performed BCA assay, were evaluated in
SDS-PAGE analysis, no acceptable protein loading control is available for trichomonads. Thus,
densitometric quantification of antigen presence was not performed.
Indirect immunofluorescence assays were used as an additional qualitative methodology
to confirm presence of epitopes 1.15 and 1.17 in feline T. foetus. Immunofluorescence was first
confirmed using a bovine T. foetus isolate obtained from a naturally infected bull (Auburn
University) for both 1.15 (Fig. 2A) and 1.17 (Fig. 2B). Both feline T. foetus isolates displayed
positive fluorescence (Fig. 3) following application of mAbs 1.15 (Fig. 3 A, B) and 1.17 (Fig. 3
C, D). No fluorescence was observed following application of either mAb to P. hominis (Fig. 4A,
B). All trichomonad populations were negative for fluorescence following omission of all
antibodies (i.e. auto-fluorescent controls) and after application of secondary antibody alone (i.e.
negative controls).
Epitopes 1.15 and 1.17 are expressed on the surface of feline T. foetus: Flow cytometry
was used to confirm surface localization of epitopes 1.15 and 1.17. Figure 5 graphically represents
the positive fluorescence of one bovine and one feline T. foetus isolate following treatment with
mAb 1.15 or 1.17, and the relative negative fluorescence of the respective auto and negative control
populations. The use of a sodium azide without a permeabilizing agent such as formalin, prevented
surface capping (i.e. inversion of the cell membrane) and confirmed positive fluorescence was due
to the presence of a surface localized, rather than intracellular, antigen. Feline T. foetus isolates
demonstrated surface expression of T. foetus mAb 1.15 (5A) and 1.17 (5B). The average mean
fluorescence of all bovine T. foetus treatment groups for auto fluorescence, negative control and
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trichomonads treated with either mAb 1.15 or 1.17 were 1.7, 6.1, 15.7 and 22.9 mean fluorescent
units (MFUs), respectively. Average mean fluorescence of bovine controls following addition of
mAbs 1.15 and 1.17 were 2.9 and 3.8 times greater than the negative control, respectively. The
average fluorescence of auto-fluorescent and negative control populations of feline T. foetus isolate
A were 3.4 and 45.3 MFUs, while treatment with mAb 1.15 or 1.17 yielded 55.2 and 97.7 MFUs.
Isolate A had average MFUs 1.2 and 2.2 times greater than that of negative control populations
following addition of mAbs 1.15 and 1.17. Similarly, feline T. foetus isolate Sti had autofluorescent and negative control MFUs of 17.5 and 63.3, which increased to 82.7 and 128.3 MFUs
with addition of mAbs 1.15 and 1.17, respectively. This resulted in average MFUs that were 1.3
and 2 times greater than negative control populations for isolate Sti. The single feline P. hominis
isolate had auto-flourescent and negative MFUs that were equivalent, with the negative control
population only 4% more fluorescent than the negative control. Addition of mAbs 1.15 and 1.17
to P. hominis resulted in MFUs also equivalent to those of the negative control populations, with
populations that were only 9% and 17% less fluorescent, respectively. Mean fluorescence units of
mAb-treated groups were compared to negative control populations (receiving only FITCconjugated secondary antibody) to provide an accurate reflection of fluorescence secondary to the
presence of antigen rather than background fluorescence and non-specific binding of secondary
antibody.
Surface protein 1.15-1.17 does not participate significantly in feline T. foetus adhesion
to or cytotoxicity towards the intestinal epithelium: To investigate the role epitopes 1.15 and 1.17
play in facilitating adhesion and cytotoxicity of feline T. foetus to the intestinal epithelium,
adhesion and cytotoxicity assays were performed. Figure 6 displays a representative image from
an adhesion assay, illustrating a CFSE-labeled trichomonad adhering to an IPEC-J2 cell. No
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difference in adhesion was observed among groups at the 6 hour time point for mAb 1.15 (Fig. 7).
However, there was a significantly increased number of 1:100 mAb 1.17 treated-feline T. foetus
adhered to IPEC-J2 cells (P < 0.05) when compared to monolayers infected with isotype controltreated feline T. foetus at the 6 hour time point (Fig. 8). T. foetus uninfected IPEC-J2 monolayers
had significantly less cytotoxicity (P < 0.001) as compared to treatment groups following 24 hours
of co-culture for both mAbs 1.15 and 1.17 (Fig. 9 A and B). However, there was not a significant
ameliorative effect of treatment with either mAb on feline T. foetus-infected monolayers compared
to isotype control-treated monolayers (P > 0.05). No evidence of positive fluorescence was seen
following application of mAbs 1.15 and 1.17 to IPEC-J2 cells, eliminating the possibility of nonspecific binding to the epithelial cells themselves.

Discussion
Bovine T. foetus infects the reproductive tract in cattle. However, despite the difference in
organ tropism, bovine and feline T. foetus are genetically similar and utilize analogous virulence
factors in their pathogenesis. (Morin-Adeline et al., 2014; Slapeta et al., 2012; Tolbert et al., 2014)
Given the role of the previously discovered bovine T. foetus surface antigen, 1.15-1.17, in
mediating adhesion-dependent T. foetus induced cytotoxicity, it represented an appealing marker
for exploration as a diagnostic or therapeutic target in feline trichomonosis.
Our first study objective was to determine if feline T. foetus also expressed antigen 1.151.17 and if this antigen was conserved across multiple feline T. foetus isolates. Using
immunoblotting and immunofluorescence, we demonstrated that antigen 1.15-1.17 was expressed
by all 12 feline T. foetus isolates tested. Moreover, an isolate of Pentatrichomonas hominis, a
nonpathogenic feline intestinal trichomonad that can be confused for T. foetus using in-clinic
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diagnostics such as fecal smear and In-Pouch™ TF culture (Ceplecha et al., 2013; Gookin et al.,
2003), did not express antigen 1.15-1.17. Flow cytometric evaluation demonstrated that, similar to
the bovine genotype, this antigen was located on the surface of feline T. foetus, which would be
important for the use of a drug targeting living trichomonads. The culmination of our initial results
suggested that antigen 1.15-1.17 may represent a novel target for the diagnosis or therapy of feline
T. foetus infection.
Antigen 1.15-1.17 is also recognized to be an important virulence factor for bovine T.
foetus where it functions as an adhesin, facilitating attachment of the parasite to the urogenital
epithelium. The antigen could be targeted to reduce bovine T. foetus cytopathogenicity both in
vitro and in vivo. Treatment of bovine T. foetus with monoclonal antibodies directed against the
two surface epitopes (i.e. 1.15 and 1.17) significantly reduced trichomonad adhesion to the bovine
vaginal epithelium in vitro. Following vaccination with purified T. foetus 1.17, immunized heifers
developed a robust local IgG response (Ikeda et al., 1995) and cleared infections more rapidly than
non-vaccinated cattle, with 80% of immunized heifers clearing infections by week 7 post infection
in comparison to only 37% of control heifers. (Anderson et al., 1996; Bondurant et al., 1993;
Corbeil et al., 1998; Corbeil et al., 2001) Vaccinated animals also exhibited decreased severity of
endometritis as assessed by histopathology than non-vaccinated cattle. (Anderson et al., 1996)
Additionally, immunization of bulls with T. foetus 1.17 protected against trichomonad colonization
of preputial and penile epithelium. (Cobo et al., 2009).
Given the precedential role established for antigen 1.15-1.17 in bovine cytopathogenicity,
a second objective of the present study was to evaluate antigen 1.15-1.17 as a potential therapeutic
target for feline trichomonosis. These studies were performed with a previously validated coculture model system (Tolbert et al., 2014; Tolbert et al., 2013) using porcine jejunal epithelial
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(IPEC-J2) cells because no feline intestinal epithelial cell line is available. Feline T. foetus and
porcine T. foetus, formerly known as Tritrichomonas suis, are genetically similar and both have a
tropism for the gastrointestinal tract. (Mostegl et al., 2011; Slapeta et al., 2012; Tachezy et al.,
2002) Given that no feline intestinal cell culture lines exist and it has previously been shown that
feline T. foetus are capable of causing cytotoxicity to IPEC-J2 cells (Tolbert et al., 2014), these
porcine epithelial cells are the most appropriate substitute. To characterize the role of antigen 1.151.17 in feline T. foetus infection, feline T. foetus were pre-treated with monoclonal antibodies
(mAbs) directed against two epitopes of antigen 1.15-1.17 prior to co-culture with IPEC-J2
monolayers. In contrast to bovine T. foetus, neither inhibition of epitope 1.15 or 1.17 reduced
adhesion of feline T. foetus to the intestinal epithelium. Rather, mAb treatment of feline T. foetus
resulted in either no change or an increased ability to adhere to intestinal epithelial cells when
compared to control-treated T. foetus. These findings suggest that antigen 1.15-1.17 is not critically
important for promoting adhesion of feline T. foetus to the intestinal epithelium in vitro.
Previous studies have demonstrated the critical role of feline T. foetus adhesion to the
parasite’s induction of intestinal epithelial cell cytotoxicity. (Tolbert et al., 2013) Thus, it is
unsurprising that, since 1.15-1.17 was not found to mediate adhesion, neither mAb 1.15 or 1.17
treatment ameliorated feline T. foetus destruction of IPEC-J2 cells. The reasons for the discrepancy
in roles of the antigen between genotypes are unknown, but may be explained by differences in
transmission (fecal-oral versus sexually transmitted) and/or organ tropism. Another possibility,
considered less likely in the authors’ opinion, is that the porcine nature of the intestinal epithelial
cells used in this study may not reflect what would be seen with feline specific intestinal epithelial
cells. As there are no commercially available feline intestinal epithelial cell lines with which to
conduct these studies, porcine cells represent the next most suitable alternative, as feline and
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porcine T. foetus (formely known as Tritrichomonas suis) are highly similar organisms that both
demonstrate a unique tropism for the gastrointestinal tract and have recently been classified as the
same species. (Slapeta et al., 2012) Although there are similarities between organisms, we cannot
discount the possibility that a difference in in vitro epitope function would be seen with feline
epithelial cells. Lastly, we cannot exclude the possibility of antibody degradation by T. foetussecreted proteases (Kania et al., 2001), which would interfere with our ability to examine the effect
of antibody treatment on the parasite. However, we think the latter is less likely as feline T. foetus
have been demonstrated to secrete very little proteases compared to the bovine genotype. (Tolbert
et al., 2014; Talbot et al., 1991; Thomford et al., 1996)
In conclusion, the present work demonstrates that feline T. foetus possess the previously
identified bovine T. foetus antigen 1.15-1.17. The surface antigen was shared across all feline
isolates tested. Documentation of this antigen in feline T. foetus isolates provides continued
evidence of similarities between feline and bovine genotypes. Interestingly, unlike the bovine
genotype, antigen 1.15-1.17 was not found to mediate adhesion to or exertion of cytotoxicity
towards the intestinal epithelium in an in vitro model. We hypothesize that differences in pathogen
transmission and host-specific organ tropism (i.e. direct deposition into the vaginal vault versus
fecal-oral transmission and migration to the large intestines) may contribute to differences in the
function of the antigen between genotypes. As antigen 1.15-1.17 was absent in the non-pathogenic
feline intestinal trichomonad, Pentatrichomonas hominis andwas conserved across all feline T.
foetus isolates evaluated, this antigen represents a candidate marker for development of a novel,
on-site diagnostic assay to detect whole organism T. foetus in feline fecal samples.
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Figure 1. Western blot confirms presence of antigen 1.15-1.17 in feline T. foetus (Tf) isolates and
absence in Pentatrichomonas hominis (P. hominis). For both A and B, protein lysates were
harvested from 2 bovine Tf isolates (lanes 3-4), 13 feline Tf isolates (5 depicted here are: A, Sti,
Ja, Mo and F isolates; lanes 5-9) and 1 feline P. hominis isolate (lane 10). Immunoblotting
confirms the presence of epitopes 1.15 (1A) and 1.17 (1B) following addition of anti-1.15 (1A)
and 1.17 (1B) specific mAbs. P. hominis was negative for the presence of both epitopes. The
diffusely migrating appearance of the band is characteristic for glycosylated proteins.
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Figure 2. Indirect immunofluorescence confirms presence of surface antigen 1.15-1.17 in a
bovine T. foetus (Tf) isolate (Aub). Fluorescence was noted following addition of both 1:100
mAb 1.15 (A) and mAb 1.17 (B). An auto-fluorescent (i.e. lacking application of all antibody),
and negative (i.e. lacking addition of primary antibody only) controls were also evaluated when
testing the bovine isolate. Neither control population displayed positive fluorescence. 1000x
magnification.
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Figure 3. Indirect immunofluorescence confirms presence of surface antigen 1.15-1.17 in feline
T. foetus (Tf) isolates. Positive fluorescence is observed following addition of 1:100 mAb 1.15
and 1.17 in feline Tf isolate A (A and C, respectively) and isolate S (B and D, respectively). An
auto-fluorescent (i.e. lacking application of all antibody), and negative (i.e. lacking primary
antibody only) control was performed for each isolate. Neither control population displayed
positive fluorescence. All images were captured at either 400 or 1000x magnification.
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Figure 4. Indirect immunofluorescence demonstrates absence of antigen 1.15-1.17 in a feline
Pentatrichomonas hominis (P. hominis) isolate. No fluorescence was observed following
addition of either 1:100 mAb 1.15 (A) or 1.17 (B) in a feline P. hominis isolate. An autofluorescent (i.e. lacking application of all antibody), and negative (i.e. lacking primary antibody
only) control also performed. 1000X magnification.
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Figure 5. Flow cytometry confirms surface localization of antigen 1.15-1.17 in a feline T. foetus
(Tf) isolate. Histograms denote positive fluorescence in one feline Tf isolate (Isolate Sti; A, B),
one bovine Tf isolate (C, D), and negative fluorescence in a P. hominis isolate (E, F) following
addition of mAb 1.15 or 1.17 and FITC-conjugated goat anti-mouse F(ab’)2 IgG + IgM
secondary antibody. For all histograms, the X axis represents the mean fluorescence intensity
(FITC) on a logarithmic scale and the Y axis the cell count. Each peak, moving from left to right
along the X axis, represents the mean fluorescence of the following groups: auto fluorescence
(i.e. lacking addition of any antibody), negative control (i.e. lacking addition of primary
monoclonal antibody but treated with 1:100 FITC-conjugated secondary antibody) and positive
fluorescence following application of either mAb 1.15 (A, C, E) or mAb 1.17 (B, D, F) with
FITC-conjugated secondary antibody. Assays were performed in triplicate with 10,000 events
counted for each treatment population.
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Figure 6. A Carboxyfluorescein diacetate, Succinimidyl Ester (CFSE) stained feline T. foetus
(isolate A) adheres to an intestinal epithelial cell. Live trichomonads were labeled with CFSE, a
viable stain, and co-cultured at 37°C in 5% CO2 with IPEC-J2 cells on 24-well polystyrene
plates. Following co-culture for 6 hours, IPEC-J2 monolayers were washed twice with DPBS to
remove unbound trichomonads and DAPI, a vital stain, was applied to stain the nucleus of living
trichomonads and IPEC-J2 cells. 800X magnification.
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Figure 7. Epitope 1.15 does not facilitate adhesion of feline T. foetus to intestinal epithelial cells.
The mean number of adhered trichomonads to IPEC-J2 monolayers after 6 hours of co-culture in
presence of 10 x 106 feline T. foetus (isolate A) treated with either 1:100 isotype control (white
bar; unlabeled mouse IgG) or mAb (black bar; 1.15). Data represent n=6 cultures per treatment
and are reported as means + SD. Determined by a Student’s t-test. All assays were performed in
triplicate.
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Figure 8. Epitope 1.17 does not promote adhesion of feline T. foetus to intestinal epithelial cells.
The mean number of adhered trichomonads to IPEC-J2 monolayers after 6 hours of co-culture in
the presence of 10 x 106 feline T. foetus (isolate A) treated with either 1:100 isotype control
(white bar; unlabeled mouse IgG) or mAb (black bar; 1.17). Data represent n=6 cultures per
treatment and are reported as median + SE. *P < 0.05 between groups. Determined by a MannWhitney rank sum test. All assays were performed in triplicate.
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Figure 9. Antigen 1.15-1.17 does not promote T. foetus-induced intestinal epithelial cell
cytotoxicity in vitro. Spectrophotometric analysis of crystal violet absorbance of IPEC-J2
monolayers following 24 h co-culture in the absence (white bars) or presence of 10 x 10^6 feline
T. foetus (isolate A) pre-treated with either 1:100 mAb [black bars; 1.15 (A) or 1.17 (B)] or
isotype control (gray bars; unlabeled mouse IgG). Data represent n=6 cultures per treatment and
are reported as means ± SD. ***P < 0.0001 **P < 0.001 compared to T. foetus-infected
monolayers. Determined by a one-way ANOVA and post-hoc Holm-Sidak. All assays were
performed in triplicate.
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previously discovered bovine T. foetus surface protein is conserved across and also surface
localized in feline T. foetus isolates. These properties make it an ideal candidate for future
development of a rapid, in-clinic assay to accurately differentiate cats with trichomonosis versus
other protozoal causes of large bowel diarrhea.
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